Login/Sign Up
₹8856*
MRP ₹10800
18% off
₹9180*
MRP ₹10800
15% CB
₹1620 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Country of origin
Alcohol
Unsafe
Avoid alcohol consumption while on treatment with Dashori 70 Tablet 60's to prevent serious adverse effects.
Pregnancy
Unsafe
When given to a pregnant woman, Dashori 70 Tablet 60's may cause fetal harm. There have been no sufficient and well-controlled investigations of Dashori 70 Tablet 60's in pregnant women. Women of reproductive potential should avoid becoming pregnant while undergoing treatment with this medicine.
Breast Feeding
Unsafe
It is not known if Dashori 70 Tablet 60's passes into your breast milk. Inform your doctor if you are breastfeeding. You should not breastfeed while taking this medicine and for 2 weeks of the treatment with Dashori 70 Tablet 60's. Your doctor may prescribe an alternative based on the symptoms and health condition.
Driving
Unsafe
Dashori 70 Tablet 60's may cause dizziness and may make you feel drowsy. Hence, avoid driving or operating machines after taking Dashori 70 Tablet 60's or until you become alert.
Liver
Caution
Use Dashori 70 Tablet 60's with caution if you have liver disease. Your doctor may monitor your liver function while taking this medicine. No dose adjustments are necessary in patients with liver impairment.
Kidney
Caution
There are presently no clinical investigations with Dashori 70 Tablet 60's in patients with compromised renal function. If you have kidney problems, inform your doctor before taking this medicine.
Children
Consult your doctor
Dashori 70 Tablet 60's is safe for use in children above one year of age if prescribed by the doctor.
Product Substitutes
About Dashori 70 Tablet 60's
Dashori 70 Tablet 60's is an anti-cancer medicine used in the treatment of Leukemia. Leukemia, also known as blood cancer, is a cancer of blood cells or blood-forming tissues. It causes excessive production of immature white blood cells by the bone marrow and reduces the body’s ability to fight infections. There are different types of blood cancers. Dashori 70 Tablet 60's is used in the treatment of chronic myelogenous leukemia (CML) in patients with chronic, accelerated, or blast phase Ph+ (Philadelphia chromosome-positive) who are resistant or intolerant to prior therapy, in patients with newly diagnosed chronic Ph+ chronic myelogenous leukemia (CML). This medicine is also used in the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).
Dashori 70 Tablet 60's contains Dasatinib, which belongs to the class of kinase inhibitors. It works by inhibiting the action of abnormal proteins that cause the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body.
Dashori 70 Tablet 60's may cause certain side effects, such as skin rash, fatigue, headache, musculoskeletal pain, decreased platelet count, nausea, vomiting, diarrhea, abdominal pain, dizziness, GI bleeding, muscle inflammation, myalgia, and difficulty breathing. These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor. Dashori 70 Tablet 60's should be taken as advised by your doctor. Do not take more than the recommended dose of medicine. Your doctor will decide the dose of Dashori 70 Tablet 60's based on the severity of your condition.
Dashori 70 Tablet 60's should be avoided if you are allergic to it or any other components present in it. Before taking Dashori 70 Tablet 60's, caution should be exercised if you have/had liver/kidney disease, gastrointestinal disorders, cardiac problems, and myelosuppression as may cause serious side effects or worsen such conditions. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment with Dashori 70 Tablet 60's. Breastfeeding should be discontinued in nursing mothers during the treatment.
Uses of Dashori 70 Tablet 60's
Medicinal Benefits
Dashori 70 Tablet 60's contains Dasatinib, which belongs to the class of kinase inhibitors. It works by inhibiting the action of abnormal proteins (BCR-ABL tyrosine kinase) that cause the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body. Dashori 70 Tablet 60's is used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia.
Directions for Use
Side Effects of Dashori 70 Tablet 60's
Drug Warnings
Dashori 70 Tablet 60's should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before taking, inform your doctor if you have liver/kidney disease, diabetes, cardiac problems, increased blood pressure, or gastrointestinal disorders, as the use of Dashori 70 Tablet 60's in these patients may cause serious side effects. Dashori 70 Tablet 60's may cause myelosuppression, fluid retention, gastrointestinal haemorrhage, QT prolongation, congestive heart failure, Left ventricular dysfunction and Myocardial infarction. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment. Breastfeeding should be discontinued in nursing mothers during the treatment. Dashori 70 Tablet 60's is given in children above one year of age only if prescribed by the doctor. Avoid alcohol consumption and smoking, as it can lead to serious adverse effects.
Drug-Drug Interactions
Drug-Food Interactions
Drug-Diseases Interactions
Drug-Drug Interactions Checker List
Habit Forming
Special Advise
Diet & Lifestyle Advise